CNE100003ZH1
CNE100003ZH1
GAN&LEE PHARMACEUTICALS CO LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 45.16B EUR | 33.9B EUR | 38.23B EUR |
Enterprise Value | 41.42B EUR | 31.39B EUR | 36.07B EUR |
Valuation Multiples | |||
Trailing P/E | 38.93x | 27.64x | 34.09x |
Forward P/E | 39.75x | -- | -- |
Price to Sales | 10.73x | 7.87x | 9.68x |
Price to Book | 3.87x | 2.9x | 3.23x |
EV/Revenue | 9.84x | 7.28x | 9.13x |
EV/EBITDA | 34.29x | 18.74x | 26.5x |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -0.45% | -0.62% | -0.66% |